Publications

1. Masoudi, M., Ahangarian, N., Ammarlou, H. (2026). SH3D21 rs34416442 genetic variation is associated with pancreatic cancer patients’ overall survival and their response to gemcitabine. Molecular Biology Research Communication. 15,159-164.

2. Masoudi, M., Akbarzadeh Aghdam, M., Ghods, A. (2026). Impact of an Earthquake Sequence on Sex Ratio at Birth in Sarpol-e Zahab County. Iranian Journal of Geophysics. 

3. Salah, F., Masoudi, M., Ghasemian Roudsari, F., Ramezani, S. (2025). Inhibitory Properties of Cannabis sativa Seed Extract on Pancreatic Cancer Cells. bioRxiv

4. Masoudi, M., Torabi, P., Judson-Torres, R.L., Khodarahmi, R., Moradi, S. (2024). Natural resistance to cancer: A window of hope. Int. J. Cancer. 154,1131-1142.
   
5. Sadeghi, H., Masoudi, M., Torabi, P., Rezaeiani, S., Movahedi, F., Pahlavan, S., Moradi, S. (2023). Conditioned media from human pluripotent stem cell-derived cardiomyocytes inhibit the growth and migration of lung cancer cells. J. Cell. Biochem. 124, 446-458. 

6. Masoudi, M. (2021). Lessons from a genome-wide CRISPR-Cas9 screening: what researchers should know before start. EXCLI Journal. 20, 1615-1620. 

7. Masoudi, M., Seki, M., Yazdanparast, R., Yachie, N., Aburatabi, H. (2019). A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine. Sci Rep. 9, 19188. 

8. Tsutsumi, R., Masoudi, M., Takahashi, A., Fujii, Y., Hayashi, T., Kikuchi, I., Satou, Y., Taira, M., Hatakeyama, M. (2013). YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev Cell.
26, 658-665. 

9. Masoudi, M., Saadat, I., Omidvari, S., Saadat, M. (2011). Association between N142D genetic polymorphism of GSTO2 and susceptibility to colorectal cancer. Mol. Biol. Rep. 7, 4309-4313. 

10. Masoudi, M., Saadat, I., Omidvari, S., Saadat, M. (2010). Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer.
Breast Cancer Res. Treat. 120, 263-265. 

11. Masoudi, M., Saadat, I., Omidvari, S., Saadat, M. (2009). Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol. Biol. Rep. 36, 781-784. 

12. Masoudi, M., Saadat, M. (2008). Arsenic, GSTO2 ASN142ASP polymorphism, health and treatment. EXCLI Journal. 7, 115-118. 

13. Saadat, M., Masoudi, M., Zendehboody, Z. (2007). Genotoxicity of Gasterolan (an herbal product) on chromosomes of cultured human lymphocytes and rat bone marrow. J. Pharmacol. Toxicol. 2,
304-306. 

14. Masoudi, M., Saadat, M. (2007). Altitude, latitude and sex ratio at birth in Iran. J. Epidemiol. Community Health. 61, 172-175.